In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Device/Diagnostics Quarterly Dealmaking Statistics, Q3 2018

A look at the financing, M&A and alliance activity in July–September 2018

Executive Summary

Third quarter device financing totaled $2.6 billion, a 24% decrease from the $3.4 billion brought in during Q2. The change partially stems from a sharp decline in debt financing. During the third quarter, debt raises brought in $258 million, just 10% of the Q3 total, while in the previous quarter, aggregate debt (at $947 million) represented 28% of the financing total.


Related Content

Medtronic Buys Mazor Robotics For $1.3Bn
Stryker Takes A Shine To Photonics Firm Invuity
Boston Scientific Invests In Urology With $600M Augmenix Acquisition
Genomics CEO Says Vertex R&D Pact, £25m Series B Secure Its Viability
Stryker Makes Big Investment In Spine Surgery With $1.4Bn K2M Acquisition
Wright To Pay $435M For Cartiva To Add Synthetic Cartilage Implant


Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts